Marie Yurkovich
Direttore operativo presso Oak Hill Bio Corp.
Profilo
Marie Yurkovich is currently the Vice President, Head-Strategy & Operations at Oak Hill Bio Corp.
Prior to this, she worked as an Associate at Vectr Ventures Ltd from 2019 to 2020.
Posizioni attive di Marie Yurkovich
Società | Posizione | Inizio |
---|---|---|
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Direttore operativo | - |
Precedenti posizioni note di Marie Yurkovich
Società | Posizione | Fine |
---|---|---|
Vectr Ventures Ltd
Vectr Ventures Ltd Investment ManagersFinance Vectr Ventures Ltd is a venture capital firm founded in 2009 by Arthur Law, Alan Chan, Jason Best, Mark Munoz and Adrian Chan. The firm is headquartered in Hong Kong. | Analista di Private Equity | 01/02/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Vectr Ventures Ltd
Vectr Ventures Ltd Investment ManagersFinance Vectr Ventures Ltd is a venture capital firm founded in 2009 by Arthur Law, Alan Chan, Jason Best, Mark Munoz and Adrian Chan. The firm is headquartered in Hong Kong. | Finance |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Marie Yurkovich